Title: Role and Side Effects of Topical Phenytoin Dressing in Diabetic Foot Ulcer as Compared to Conventional Betadine Dressing

Authors: Dr Shrirang Yadwadkar, Dr Mrs.Thipse, Dr Sudhir Mutha, Dr Niranjan Dash, Dr Atul Khalkar, Dr Jayant Gadekar

 DOI:  http://dx.doi.org/10.18535/jmscr/v3i12.52

Abstract

Diabetic ulcer is the most frequent reason for hospitalization in patients with diabetes. It has increased the cost of treatment and hospitalization of these patients.

Currently a lot of attention is being placed on the development of expensive topical growth factors for wound healing. Thus there remains a quest for better wound healing agents. One such agent is phenytoin which is cheap, easy to use and readily available for medical practice. Phenytoin (diphenylhydantoin) was initially introduced into therapy for the effective control of convulsive disorders. A common side effect with systemic phenytoin treatment is the development of fibrous overgrowth of gingiva. This apparent stimulatory effect of phenytoin on connective tissue suggested an encouraging possibility for its use in wound healing. In this study, the wound-healing efficacy of phenytoin was investigated as compared to the conventional betadine dressings.

Keywords:topical phenytoin ,diabetic foot ulcer, betadine ,wound healing, granulation ,epithelisation

References

1.      Steed DT, Donahoe D, Webster MW, Linsley L. Diabetic ulcer study Group : Effect of extensive debridement and treatment on the healing of diabetic foot ulcers. J Am Coll Surg 1996;183:61-4.

2.      Clark RA. Basis of cutaneous wound repair. J Dermatol Surg Oncol. 1993;19:693–706. [PubMed: 8349909]

3.      Anstead GM, Hart LM, Sunahara JF, Liter ME. Phenytoin in wound healing. Ann Pharmacother. 1996;30:768–75. [PubMed: 8826558]

4.      Shapiro M. Acceleration of gingival wound healing in non-epileptic patients receiving diphenylhydantoin sodium. Exp Med Surg 1958;16:41-53

5.      Talas G, Brown RA, McGrouther A. Role of phenytoin in Wound healing a wound pharmacology perspective Biochem Pharmacol 1999;57(10):1085-94.

6.      Banal NK, Mukul. Comparison of topical phenytoin with normal saline in the treatment of chronic tropic ulcers in leprosy. IM J Dermatol 1993:32:210-3.

7.      Muthukumaraswamy MG, Sivakumar G, Manoharan G. Topical phenytoin in diabetic loot ulcers. Diabetes Care 1991;14:909-11

8.      Lodha SC, Lohiya ML, Vyas MCR, Bhandari S. Goyal RR, Harsh MK. Role of phenytoin in healing of large abscess cavities. BrJ Surg 1991;78:105-8.

9.      Yadhav JK, Singhvi AM, Kumar N, Garg S. Topical phonytoin in the treatment of split thickness skin autograft donor sites: a comparative study with polyurethane membrane drape and conventional dressing. Bums 1993;19:306-10.

10.  Anstead GH, Hart LM, Sunahara JF, Liter ME. Phenytoin in wound healing. Ann Pharmacother 1996:30:769-75.

11.  Kumar S. Boulton AJM. Response to Topical pherrytoin in diabetic foot ulcers'. Diabetes Care 1992;15:1433-4

Corresponding Author

Dr Shrirang Yadwadkar

* Address – Dept. Of Surgery, PDVVPF’S Medical College and Hospital,

Vilad Ghat, Ahmednagar, India. Pin- 414111

Email: This email address is being protected from spambots. You need JavaScript enabled to view it., *Phone No:08855022933